Economic implications of failure to reduce incident HIV infections by 50% by 2005 in the United States

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 2, 2003, Pages 171-174

  Holtgrave, David R ^a   Pinkerton, Steven D ^b  

^a EMORY UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Acquired immunodeficiency syndrome; Cost and cost analysis; Health services needs and demand; HIV; MESH headings; Primary prevention

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TREATMENT FAILURE; UNITED STATES;

EID: 0038078716     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200306010-00009     Document Type: Article

References (14)

1. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science. 1991;253:37-42.
2. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001;91:1060-1068.
3. Holtgrave DR, Pinkerton SD. Implications of economic evaluation for national HIV prevention policy makers. In Kaplan EH, Brookmeyer R, eds. Quantitative evaluation of HIV prevention pro-grains. New Haven, CT: Yale University Press, 2002.
4. Centers for Disease Control and Prevention. HIV prevention strategic plan through 2005. Atlanta, GA: Centers for Disease Control and Prevention, 2001.
5. National Alliance of State and Territorial AIDS Directors. FY2002 appropriations levels for federal AIDS programs., Available at: http://www.nastad.org/PDF/FY2002%20APPROPS%20CHART% 20DOC.PDF. Accessed January 10, 2002.
6. Holtgrave DR. Reducing new HIV infections by one-half: what will it take? Putting the goal in historical context, and assessing the cost of unmet needs. Presented at the 2001 National HIV Prevention Conference, Atlanta, August 2001.
7. Janssen RS, Holtgrave DR, Valdiserri RO, et al. Serostatus approach to fighting the HIV epidemic: prevention strategies for individuals living with HIV in the United States. Am J Public Health. 2001;91:1019-1024.
8. Holtgrave DR, Pinkerton SD, Merson M. Estimating the cost of unmet HIV-prevention needs in the United States. Am J Prev Med. 2002;23:7-12.
9. Centers for Disease Control and Prevention. A glance at the HIV epidemic. Available at: http://www.cdc.gov/hiv/publs.facts.htm. Accessed September 6, 2002.
10. Chen SY, Gibson S, Katz MH, et al. Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2002. Am J Public Health. 2002;92:1387-1388.
11. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men in San Francisco. Am J Public Health. 2002; 91:388-394.
12. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 16:54-62.
13. Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS Behav. 1998;2:189-201.
14. Gold MR, Siegel JE, Russell LB, et al., eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.